News | EP Mapping and Imaging Systems | June 12, 2018

Volta Medical Brings Artificial Intelligence to Cardiac Electrophysiology

Smart software AIFib guides cardiologists through atrial fibrillation procedures

Volta Medical Brings Artificial Intelligence to Cardiac Electrophysiology

June 12, 2018 — Volta Medical, out of Marseille, France, has developed the first artificial intelligence (AI) software to guide cardiologists during heart surgeries to treat atrial fibrillation (AF) or any open-heart surgery.

In January 2017, the co-founders published their first article in the Journal of the American College of Cardiology (JACC) that had garnered great interest in the field.

AIFib is an artificial intelligence software developed to guide doctors through the complex medical procedure intended to treat atrial fibrillation — from the detection of electrical foci, which trigger atrial fibrillation, to the surgery itself. AIFib is based on more than 10 years of intense research and development by the co-founders, alongside a team of engineers led by Théophile Mohr Durdez, who developed the software and runs the company.

At the 2018 Heart Rhythm Society (HRS) Conference, May 9-12 in Boston, Jérôme Kalifa, M.D., Ph.D., co-founder of Volta Medical, presented the results of a test performed by 28 expert cardiologists and Volta's software. The test consisted of analyzing intracardiac electrical signals during the surgical ablation of atrial fibrillation, and the performance of the AIFib software surpassed those recorded a few months earlier by a panel of 28 cardiologists. Studies are underway to confirm this promising preliminary data.

To identify electrical foci, the root cause of fibrillation, cardiologists previously had to manipulate probes inside the heart in order to identify the electrical signals and detect them visually. The technique is hard to master, however, and surgeons have to analyze very complex sets of intracardiac electrical signals. Volta Medical had the idea to model and automate this technique as a way to make it accessible to a large number of surgeons.

AF manifests itself by an anarchic, rapid and irregular heart rate. These chaotic heartbeats prevent the heart from properly pumping blood. The root cause is an "electrical storm" in the atria disrupting all synchronized activities to a point that the mechanical contraction of the atria no longer occurs. The heart loses its strength. The ventricle may momentarily compensate for this loss, but in the long run, the exhaustion of its contractile forces can lead to heart failure. Atrial fibrillation can cause a blood clot in the heart, which may migrate into the brain arteries and cause a stroke.

For more information: www.volta-medical.com

References

Seitz J., Bars C., Théodore G., et al. "AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach." Journal of the American College of Cardiology, Jan. 24, 2017. DOI: 10.1016/j.jacc.2016.10.065


Related Content

News | Artificial Intelligence

April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more ...

Home April 06, 2024
Home
News | Artificial Intelligence

March 28, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...

Home March 28, 2024
Home
News | Artificial Intelligence

March 27 2024 — HeartFlow, Inc., a leader in AI-driven healthcare technology, announced the launch of the DECIDE ...

Home March 27, 2024
Home
News | Artificial Intelligence

March 7, 2024 — GE HealthCare will showcase its industry-leading portfolio of artificial intelligence (AI)-enabled ...

Home March 07, 2024
Home
News | Artificial Intelligence

March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict ...

Home March 01, 2024
Home
News | Artificial Intelligence

February 28, 2024 — Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many challenges ...

Home February 28, 2024
Home
News | Artificial Intelligence

February 23, 2024 — Cleerly, the company creating a new standard of care to aid in the diagnosis of heart disease ...

Home February 23, 2024
Home
News | Artificial Intelligence

February 16, 2024 — Cardio Diagnostics Holdings, Inc., an AI-driven precision cardiovascular medicine company, announced ...

Home February 16, 2024
Home
News | Artificial Intelligence

February 13, 2024 — Cleerly, a digital healthcare company focused on artificial intelligence (AI)-driven heart disease ...

Home February 13, 2024
Home
Subscribe Now